FTT - AIP
Brief description of study
patients with newly diagnosed breast cancer will undergo a research PET/CT scan using the radiotracer 18F-FTT (FluorThanatrace) to image PARP-1 activity in the tumor. A sub-set of patients will have a second PET/CT scan to evaluate test-retest reproducibility. Tissue will be collected at the time of surgery for additional research pathology analysis. The study will be carried out at 3 centers with MDACC acting as the sIRB of record.
Eligibility of study
You may be eligible for this study if you meet the following criteria:
- Conditions: Medical Research
-
Age: 99 years or below
-
Gender: All
TBD
Find a site
,
You have contacted , on
Your message has been sent to the study team at ,
What happens next?
- You can expect the study team to contact you via email or phone in the next few days.
- Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.
You are contacting
